Tech Company Financing Transactions

KineMed Funding Round

KineMed, operating out of Emeryville, received $1 million from private investors.

Transaction Overview

Company Name
Announced On
12/13/2012
Transaction Type
Debt
Venture Equity
Amount
$1,039,850
Round
Undisclosed
Investors
Proceeds Purpose
Proceeds purposes were not disclosed. SEC regulatory filing. Not a solicitation.

Company Information

Company Status
Private & Independent
Industry
Biopharmaceutical
Mailing Address
5980 Horton St. 470
Emeryville, CA 94608
USA
Email Address
Overview
KineMed, Inc. is a drug discovery and development company employing its proprietary translational medicine technology (AquaTag and KineMarker) to both identify active drug candidates preclinically and confirm their therapeutic activity and dose response in first-in-man studies.
Profile
KineMed LinkedIn Company Profile
Social Media
KineMed Company Twitter Account
Company News
KineMed News
Facebook
KineMed on Facebook
YouTube
KineMed on YouTube

Management Team

Title
Name
Email & Social
Chief Executive Officer
David Fineman
  David Fineman LinkedIn Profile  David Fineman Twitter Account  David Fineman News  David Fineman on Facebook
Chief Scientific Officer
Marc Hellerstein
  Marc Hellerstein LinkedIn Profile  Marc Hellerstein Twitter Account  Marc Hellerstein News  Marc Hellerstein on Facebook


 

 

Browse more venture capital transactions:

Prev: 12/13/2012: TetraLogic Pharmaceuticals venture capital transaction
Next: 12/13/2012: WSO2 venture capital transaction

 

Share this article

 


Where The Data Comes From

We do our best to record tech company VC transactions. VC transactions on this site are sourced from news reports and company announcements. The data is sourced from VentureDeal.com, an affiliated venture.

 


Additional Resources for Entrepreneurs

Lists of Venture Capital and Private Equity Firms

Franchise Opportunities

Contributors

Business Glossary